Difficulty: Medium
Average Score: 76%
Practice
Ten months after starting procainamide therapy for cardiac arrhythmias, a 56-year-old man develops arthritis and other symptoms consistent with drug-induced systemic lupus erythematosus. Results of a blood test are positive for antinuclear antibodies. This finding is consistent with which of the following genetic polymorphisms in drug metabolism?
Correct answer
D
Rationale
Procainamide is metabolized by N-acetyltransferase (NAT2), and slow acetylators (E) have a genetic polymorphism leading to reduced acetylation. This results in accumulation of the parent drug, which is associated with an increased risk of drug-induced systemic lupus erythematosus (SLE), characterized by antinuclear antibodies, arthritis, and systemic symptoms. Debrisoquine 4-hydroxylase (CYP2D6) deficiency affects drugs like beta-blockers, not procainamide. COMT deficiency impacts catecholamine metabolism, irrelevant here. G6PD deficiency causes hemolysis, not SLE. Phenytoin hydroxylase relates to anticonvulsant metabolism.